LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence

Journal of Clinical Apheresis

Volumn 24, Issue 5, 2009, Pages 180-185

  Patschan, Daniel ^a   Patschan, Susann ^a   Henze, Elvira ^a   Wessels, Johannes T ^a,b   Koziolek, Michael ^a   Müller, Gerhard A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UMG   (Germany)

Author keywords

Competence; Endothelial progenitor cells; Lipid apheresis; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; VASCULOTROPIN RECEPTOR 2;

ADULT; APHERESIS; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTHELIAL STEM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERLIPIDEMIA; LIPID APHERESIS; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEM CELL; STEM CELL MOBILIZATION; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIGENS, CD; BLOOD COMPONENT REMOVAL; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOPROTEINS; HUMANS; HYPERLIPIDEMIAS; LEUKOCYTE COUNT; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDES; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70449566880     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20208     Document Type: Article

References (29)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
2. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
3. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005;56:79-101.
4. Schuster MD, Kocher AA, Seki T, Martens TP, Xiang G, Homma S, Itescu S. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 2004;287:H525-H532.
5. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353.
6. Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004;14:318-322.
7. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-1169.
8. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004;24:684-690.
9. De Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004;66:641-646.
10. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, Redwood SR, Pearson JD, Marber MS. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004;109:2986-2992.
11. Assmus B, Honold V Jr, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. The N Engl J Med 2006;355:1222-1232. Available at http://www.ncbi.nlm.nih.gov/pubmed/16990385.
12. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR41 hemangiocytes. Nat Med 2006;12:557-567.
13. Assmus B, Urbich C, Aicher A, Hofmann W, Haendeler J, Rossig L, Spyridopoulos I, Zeiher A, Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92:1049-1055.
14. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher A. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-397.
15. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102:1340-1346.
16. Schettler V, Wieland E, Armstrong V, Kleinoeder T, Grunewald R, Muller G. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management. Ther Apher 2002;6: 381-383.
17. Dihazi H, Koziolek MJ, Sollner T, Kahler E, Klingel R, Neuhoff R, Strutz F, Mueller GA. Protein adsorption during LDL-apheresis: proteomic analysis. Nephrol Dial Transplant 2008;23:2925-2935.
18. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, Cosmi L, Maggi L, Lasagni L, Scheffold A, Kruger M, Dimmeler S, Marra F, Gensini G, Maggi E, Romagnani S. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322.
19. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809.
20. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
21. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006; 291:F176-F185.
22. Patschan D, Plotkin M, Goligorsky MS. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ca ira. Curr Opin Pharmacol 2006;6:176-183.
23. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-1118.
24. Goligorsky MS. Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 2005;288: F871-880.
25. Bonomini V, Coli L, Feliciangeli G, Mosconi G, Scolari M. Long-term results: cellulosic vs. synthetic membranes. Contrib Nephrol 1995;113:120-134.
26. Bonomini V, Coli L, Scolari M, Stefoni S. Structure of dialysis membranes and long-term clinical outcome. Am J Nephrol 1995;15:455-462.
27. O'riordan E, Chen J, Brodsky S, Smirnova I, Li H, Goligorsky M. Endothelial cell dysfunction: the syndrome in making. Kidney Int 2005;67:1654-1658.
28. Chen X, Xun K, Wu Q, Zhang T, Shi J, Du G. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul Pharmacol 2007; 47:1-9.
29. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712.